NU
Neurizon Therapeutics Limited
NUZ.AX · ASX
$0.07 -5.13% (-$0.00)
1M +24.59%
Market Cap $60.5M
P/E Ratio -
Div. Yield -
ROE 125.93%
Bulios Fair Price
$0.07
5.4% downside
Trenutna cena
$0.074
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica NUZ.AX trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
1/9Valuation
41 /100
Fair P/B 4.75x
P/FCF N/A
P/FFO N/A
Growth
100 /100
Growing Book val. growth 48.46%
Rev. growth N/A
FCF growth N/A
Profitability
-
N/A FCF margin N/A
Op. margin N/A
Gross margin N/A
Quality
0 /100
Poor Asset turnover 0.00x
ROA 45.25%
ROIC 68.44%
Debt
69 /100
Low Current ratio 2.16x
Int. coverage -37.65x
Debt/Equity 0.26x
Stability
32 /100
Unstable EPS volatility 54.89%
Profitable years 0
Beta 1.31x
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o NUZ.AX
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Ben Dingle
Employees
36
Headquarters
Melbourne